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We present here the synthetic routes and the experimental data (NMR
and MS spectra) for model reactions for copper-free Huisgen 1,4-
cycloaddition, Staudinger ligation and for addition of a dithiol on a
dibromomaleimide ring. Starting materials were synthesized from the
commercially available 4-chlorophenethylamine, previously described
2-(cyclooct-2-yn-1-yloxy)acetic acid, 1-ﬂuorocyclooct-2-ynecarboxylic
acid, commercial 2-(diphenylphosphino)terephthalic acid 1-methyl
4-pentaﬂuorophenyl diester and dibromomaleimide. In all cases, the
expected compounds were obtained with good yield (50% to
quantitative). A novel synthesis of the lipid anchor DOGP3NH2 is also
described. These data were used as basis for the study reported in the
article “Smart Tools and Orthogonal Click-like Reactions onto Small
Unilamellar Vesicles” in Chemistry and Physics of Lipids [1].
& 2015 Published by Elsevier Inc. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).is an open access article under the CC BY license
/j.chemphyslip.2015.03.004
ine.bourel@unistra.fr (L. Bourel-Bonnet).
Speciﬁcations table.
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subject areaBioconjugationType of data Experimental synthesis protocols, analysis description, NMR and MS spectra
How data was
acquired1H NMR spectra at either 300 MHz, 400 MHz or 500 MHz and 13C NMR spectra at either 75 MHz,
100 MHz or 133 MHz recorded on Brucker spectrometers either 300, 400 or 500 respectively with
residual undeuterated solvent as internal reference. High-resolution mass spectra (HRMS) obtained
using an Agilent Q-TOF (time of ﬂight) 6520 and low-resolution mass spectra (LRMS) using an
Agilent MSD 1200 SL (ESI/APCI). Analytical RP–HPLC–MS performed using a C18 column
(30 mm1 mm; 1.9 μm) using the following parameters: (1) the eluent system A (0.05% TFA in H2O)
and B (0.05% TFA in acetonitrile); (2) the linear gradient t¼0 min with 98% A, t¼5 min with 5% A,
t¼6 min with 5% A, t¼7 min with 98% A, and t¼9 min with 98% A; (3) ﬂow rate of 0.3 mL min-1;
(4) column temperature 50 1C; (5) ratio of products determined by integration of spectra recorded at
210 or 254 nm; and (6) ionization mode ESI.Data format Analyzed data
Experimental factors Starting compounds were either purchased or synthesized using already published synthetic
protocols
Experimental
featuresCompounds were synthesized and their structure was identiﬁed by NMR and conﬁrmed by mass
spectrometryData source location Illkirch, France
Data accessibility Data are provided in the paperValue of the data The data presented prove the efﬁciency of bioconjugation reactions and allow reproducibility of
the syntheses. The overall work provides further tools for surface modiﬁcation of liposomes.
 The article describes a novel, easier synthesis of the lipid anchor DOGP3NH2.1. Data
All the described 1H NMR and 13C NMR spectra, as well as MS spectra, are available as annexes to
this article.
1H NMR spectra at either 300 MHz, 400 MHz or 500 MHz and 13C NMR spectra at either 75 MHz,
100 MHz or 133 MHz were recorded on Brucker spectrometers either 300, 400 or 500 respectively
with residual undeuterated solvent as internal reference. All chemical shift values (δ), coupling
constants (J) and the multiplicity (s¼singlet, d¼doublet, t¼triplet, m¼multiplet, br¼broad) are
quoted in ppm and in Hz, respectively. High-resolution mass spectra (HRMS) were obtained using an
Agilent Q-TOF (time of ﬂight) 6520 and low-resolution mass spectra (LRMS) using an Agilent MSD
1200 SL (ESI/APCI).2. Experimental design, materials and methods
Reagent grade solvents were used without further puriﬁcation. Polymer supported triphenylpho-
sphine and anhydrous CH2Cl2 were purchased from Sigma-Aldrich. The PyBOP was purchased from
Novabiochem, the DIEA was from Alfa Aesar and both were used without further puriﬁcation. Column
chromatography was carried out on silica gel 60 (Merck, 70230 mesh). Analytical RP–HPLC–MS was
performed using a C18 column (30 mm1 mm; 1.9 μm) using the following parameters: (1) the eluent
system A (0.05% TFA in H2O) and B (0.05% TFA in acetonitrile); (2) the linear gradient t¼0 min with 98%
A, t¼5 minwith 5% A, t¼6 minwith 5% A, t¼7 minwith 98% A, and t¼9 minwith 98% A; (3) ﬂow rate of
0.3 mL min1; (4) column temperature 50 1C; (5) ratio of products determined by integration of spectra
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254 nm or with KMnO4 stain.
2.1. Synthesis of the lipid anchors
See Scheme 1.
2.1.1. Preparation of ((2,3-bis((Z)-octadec-9-en-1-yloxy)propoxy)methanetriyl)tribenzene (DIB-1)
A 50% aqueous NaOH (647 mg, 16.6 mmol) solution was added to a mixture of oleyl-OMs (11)
(1.15 g, 3.30 mmol), 3-(trityloxy)propane-1,2-diol (S-1) (285 mg, 0.83 mmol) and (Bu)4NHSO4 (28 mg,
0.08 mmol). The solution was stirred at 65 1C for 3 days. CH2Cl2 (50 mL) was added and the layers
were separated. The aqueous layer was washed with CH2Cl2 (250 mL). The organic layers were
combined, dried and concentrated under vacuum. The residue was puriﬁed by chromatography on
silica gel using cyclohexane/EtOAc (100/0–95/5) as eluent to obtain 600 mg of ((2,3-bis((Z)-octadec-9-
en-1-yloxy)propoxy)methanetriyl)tribenzene (DIB-1) as a colorless oil; 1H NMR (400 MHz, CDCl3): δ
7.48–7.44 (m, 6H of C6H3), 7.32–7.24 (m, 12H of C6H5), 5.41–5.35 (m, 4H), 3.58–3.53 (m, 4H), 3.43–3.39
(m, 3H), 3.19 (m, 1H) 2.02–1.91 (m, 10H), 1.38–1.20 (m, 44H), 0.90 (t, J¼6.8 Hz, 2CH3); HRMS (ESI) m/z
calcd. for C58H90O3Liþ , 841.7050; found 841.7096.
2.1.2. Preparation of (Z)-14-((Z)-octadec-9-en-1-yloxy)-3,6,9,12,16-pentaoxatetratriacont-25-en-1-
amine (1)HO
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Scheme 1. Synthesis of DOG-PEG3-NH2: (a) 11, TBAS 0.1%, NaOH, H2O, (b) APTS, THF/MeOH (1/1), (c) 13, NaH (60%), THF, HMPA,
and (d) polymer-bound PPh3, H2O, THF.
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pentaoxatetratriacont-25-ene [2] (60 mg, 0.076 mmol) and triphenylphosphine polymer-supported
(1.48 mmol/g, 155 mg, 0.23 mmol) in THF (5 mL). The mixture was shaken at 50 1C (16 h). The volatiles
were evaporated and CH2Cl2 was added. The beads were ﬁltered and placed in a ﬁltration tube. EtOH
was added to the beads and the mixture was shaken (5 min). The mixture was ﬁltered and the beads
were placed again in the ﬁltration tube. Once again CH2Cl2 was added to the beads, the mixture was
shaken (5 min) and the beads were ﬁltered. The EtOH and CH2Cl2 washings were repeated twice. All
the EtOH and CH2Cl2 layers were combined, dried and concentrated under vacuum to obtain
quantitatively (Z)-14-((Z)-octadec-9-en-1-yloxy)-3,6,9,12,16-pentaoxatetratriacont-25-en-1-amine (1)
as a colorless oil; 1H NMR (300 MHz, CDCl3): δ 5.35–5.30 (m, 4H), 3.64–3.40 (m, 23H), 2.05–1.90 (m,
8H), 1.60–1.52 (m, 4H), 1.40–1.19 (m, 44H), 0.86 (t, J¼7.1 Hz, 6H).
2.2. Synthesis of starting materials for model reactions
2.2.1. Preparation of the N-(4-chlorophenethyl)-2-(cyclooct-2-yn-1-yloxy)acetamide (16)
PyBOP (67 mg, 0.13 mmol) was added to a CH2Cl2 (1 mL) solution of 2-(cyclooct-2-yn-1-yloxy)
acetic acid [3] (20 mg, 0.11 mmol) and DIEA (96 mL, 0.55 mmol). The solution was stirred at room
temperature (30 min) and 4-chlorophenethylamine (17 mL, 0.12 mmol) was added. The solution was
stirred at room temperature overnight. Then, the volatiles were evaporated and the crude was
puriﬁed by ﬂash column chromatography on silica gel with cyclohexane/EtOAc (7/3–0/10) as eluant to
obtain a colorless oil (15 mg, 43%); 1H NMR (400 MHz, CDCl3): δ 7.21 (d, J¼8.5 Hz, Har), 7.05 (d,
J¼8.5 Hz, Har), 6.50–6.41 (br s, NH), 4.12–4.07 (m, OCH), 3.94 (d, J¼15.2 OCHH0), 3.78 (d, J¼15.2
OCHH0), 3.45 (qd, J¼2.0, 7.0 Hz, CH2N), 2.74 (t, J¼7.0 Hz, CH2Ph), 2.16–2.10 (m, 2H), 2.02–1.95 (m, 1H),
1.85–1.78 (m, 3H), 1.61–1.53 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 20.6, 25.7 (Ccyclooctyne), 28.9
(Ccyclooctyne), 26.2, 29.6, 29.7, 34.2, 35.1, 39.7, 42.2, 68.4, 73.2, 91.2, 101.8, 128.7, 130.1, 132.4, 137.2,
169.6; HRMS (ESI) m/z calcd. for C18H22ClNO2Hþ , 320.1411 [35Cl] and 322.1411 [37Cl]; found 320.1425
[35Cl] and 322.1398 [37Cl].
2.2.2. Preparation of the N-(4-chlorophenethyl)-2-(cyclooct-2-yn-1-yloxy)-2-ﬂuoroacetamide (17)
2.2.2.1. Preparation of ethyl 1-ﬂuoro-2-oxocyclooctanecarboxylate (DIB-2).
To a stirred solution of ethyl-2-oxocyclooctane-1-carboxylate (2.70 g, 13.0 mmol) in dry
acetonitrile (75 ml) cooled to 0 1C was added Selectﬂuor (5.70 g, 16.4 mmol). The resulting mixture
was then heated in a 55 1C oil bath (16 h). After cooling to room temperature the reaction was
quenched with water (20 mL) and extracted with ethyl acetate (420 mL). The combined organic
layer was dried over anhydrous Na2SO4, ﬁltered and concentrated in vacuo to yield a clear oil (2.92 g,
99%); 1H NMR (400 MHz, CDCl3): δ 4.18 (q, J¼7.2 Hz, CH2O), 2.67–2.46 (m, 3H), 2.20–2.16 (m, 1H),
1.94–1.91 (m, 2H), 1.83–1.55 (m, 3H), 1.46–1.33 (3H), 1.23 (t, J¼7.2 Hz, CH3).
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A solution of potassium hexamethyldisilazide (0.5 M in toluene, 15.6 mL, 7.8 mmol) was added
dropwise to a stirred solution of (DIB-2) (700 mg, 3.5 mmol) in THF (40 mL) at 78 oC. After the
addition was complete the reaction mixture was maintained for 30 min and a THF (5 mL) solution of
phenyl bis(triﬂuoromethane sulfonimide) (1.4 g, 3.9 mmol) was added slowly via syringe. The reaction
was stirred at 78 oC (1 h), and then allowed to warm up and stirred to 50 oC (16 h). Methanol was
added and the volatiles were evaporated under vacuum. The crude residue was puriﬁed by ﬂash
column chromatography on silica gel using 0–10% ethyl acetate in hexane to afford (DIB-3) as a pale
yellow liquid (346 mg, 50%); 1H NMR (400 MHz, CDCl3): δ 4.24 (q, J¼7.2 Hz, CH2O), 2.32–2.22 (m, 4H),
1.98–1.80 (m, 4H), 1.69–1.65 (m, 1H), 1.53–1.50 (m, 1H), 1.25 (t, J¼7.2 Hz, CH3).
2.2.2.3. Preparation of 1-ﬂuorocyclooct-2-ynecarboxylic acid (DIB-4).
Ethyl 1-ﬂuorocyclooct-2-yne carboxylate (DIB-3) (85 mg, 0.43 mmol) and LiOH (36 mg,
0.86 mmol) were combined in 4 mL of 50% aqueous MeOH. This mixture was heated at 50 oC
(10 min). The reaction was then allowed to cool to room temperature then stirred for additional
30 min. CH2Cl2 was added and the layers were separated. Then the aqueous layer was acidiﬁed to pH2
with a 1 M aqueous solution of HCl and was washed with ethyl acetate (350 mL). The ethyl acetate
layers were combined, dried over anhydrous MgSO4, ﬁltered, and concentrated under vacuum leading
to 1-ﬂuorocyclooct-2-ynecarboxylic acid (DIB-4) as colorless oil (52 mg, 70%); 1H NMR (400 MHz,
CDCl3): δ 2.37–2.24 (m, 4H), 1.99–1.81 (m, 4H), 1.71–1.63 (m, 1H), 1.43–1.40 (m, 1H).
2.2.3. Preparation of N-(4-chlorophenethyl)-1-ﬂuorocyclooct-2-ynecarboxamide (17)
HATU (107 mg, 0.28 mmol) was added to a THF (2 mL) solution of 1-ﬂuorocyclooct-2-
ynecarboxylic acid (DIB-4) (40 mg, 0.24 mmol) and DIEA (81 mL, 0.47 mmol). The solution was stirred
at room temperature (5 min) and the 4-chlorophenethylamine (40 mL, 0.28 mmol) was added. The
solution was stirred at room temperature (16 h). The solution was concentrated under vacuum. The
residue was puriﬁed by chromatographic column on silica gel using cyclohexane/EtOAc as eluent
(100/0–80/20). The N-(4-chlorophenethyl)-1-ﬂuorocyclooct-2-ynecarboxamide (17) was obtained as a
white solid (40 mg, 60%);1H NMR (400 MHz, CDCl3): δ 7.21 (d, J¼8.4 Hz, Hm), 7.05 (d, J¼8.4 Hz, Ho),
6.30 (s, NH), 3.42–3.50 (m, CH2N), 2.75 (t, J¼7.2 Hz, CH2Ph), 2.38–2.10 (m, 4H), 2.02–1.75 (m, 4H),
1.62–1.51 (m, 1H), 1.43–1.37 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 20.6 (d, J¼2.9 Hz), 25.7, 28.9, 33.9,
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109.5 (d, J¼10.9 Hz), 128.8, 130.1, 132.5, 136.9, 168.3 (d, J¼24.8 Hz, C(O)); MS (ESI) m/z calcd. for
C17H19ClFNOHþ , 307.1 [35Cl] and 309.1 [37Cl]; found 308.0 [35Cl] and 310.0 [37Cl].
2.2.4. Preparation of the methyl 4-((4-chlorophenethyl)carbamoyl)-2-(diphenylphosphino)benzoate (18)
4-chlorophenethylamine (8 mL, 0.056 mmol) was added to a DMF (1 mL) solution of 2-
(diphenylphosphino)terephthalic acid 1-methyl 4-pentaﬂuorophenyl diester (25 mg, 0.047 mmol)
and Et3N (33 mL, 0.235 mmol). The solution was stirred at room temperature overnight. The solution
was concentrated under vacuum and the residue was puriﬁed by chromatographic column on silica
gel using cyclohexane/EtOAc as eluent (100/0–80/20). The methyl 4-((4-chlorophenethyl)carbamoyl)-
2-(diphenylphosphino)benzoate (18) was obtained as yellow oil (19 mg, 82%); 1H NMR (500 MHz,
CDCl3): δ 8.00 (dd, J¼3.5, 8.0 Hz, 1 Har), 7.65 (dd, J¼1.5, 8.0 Hz, 1 Har), 7.28–7.24 (m, 6 Har), 7.21–7.10
(m, 6 Har), 7.09–7.10 (m, 1 Har), 6.97 (d, J¼8.5 Hz, 2 Har), 5.70–5.60 (br m, NH), 3.67 (s, OCH3), 3.50 (q,
J¼7.0 Hz, CH2N), 2.70 (t, J¼7.0 Hz, CH2Ph); 13C NMR (133 MHz, CDCl3): δ 34.8, 41.0, 52.3, 127.0, 128.6,
128.7, 129.0, 130.0 131.0, 131.1, 132.1, 132.5, 133.8, 133.9, 137.0, 137.1, 166.5, 166.6; 31P NMR (500 MHz,
CDCl3): δ 3.98; HRMS (ESI) m/z calcd. for C29H25ClNO3P(O)Hþ , 518.1288 [35Cl] and 520.1288 [37Cl];
found 518.12969 [35Cl] and 520.1279 [37Cl].
2.2.5. Synthesis of biotin-OSuc (14) [4]
A mixture of biotin (2.5 g, 12.3 mmol), N-hydroxysuccinimide (2.0 g, 16.25 mmol), and EDCI (2.5 g,
13.30 mmol) was dissolved in DMF (40 mL) and stirred for 24 h at room temperature. The solution
was poured onto crushed ice and the solid obtained was ﬁltered, washed with water and dried under
vacuum to give Biotin-OSuc (2.6 g, quant.yield); 1H NMR (300 MHz, DMSO-d6): δ 6.43 (s, 1H), 6.37 (s,
1H), 4.33–4.29 (m, 1H), 4.17–4.12 (m, 1H), 3.09–3.12 (m, 1H), 2.89–2.78 (m, 6H), 2.67 (t, J¼7.4 Hz, 2H),
2.58 (d, J¼12.4Hz, 1H), 1.66–1.60 (m, 3H), 1.53–1.41 (m, 3H).
2.2.5.1. Preparation of 2-bromo-N-(4-chlorophenethyl)acetamide (DIB-5).
Bromoacetyl bromide (0.672 mL, 7.71 mmol) was added dropwise at 0 1C to a solution of 4-
chlorophenethylamine (0.9 mL, 6.43 mmol) and triethylamine (1.8 mL, 12.86 mmol) in CH2Cl2 (24 mL).
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organic phase, which was washed with HCl 1 M. After evaporation, the crude was puriﬁed by ﬂash
chromatography on silica gel (cyclohexane/AcOEt gradient 10:0–5:5) to yield 2-bromo-N-(4-
chlorophenethyl)acetamide (1.06 g, 60% yield) as a yellow solid; 1H NMR (400 MHz, CDCl3): δ 7.31
(d, J¼8.2 Hz, 2H), 7.15 (d, J¼8.2 Hz, 2H), 6.50 (bs, 1H), 3.86 (s, 2H), 3.53 (app q, J¼6.9 Hz, 2H), 2.83 (t,
J¼6.9 Hz, 2H).2.2.6. Preparation of N-(4-chlorophenethyl)-2-(3,4-dibromo-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)
acetamide (19)
M. Vittoria Spanedda et al. / Data in Brief 5 (2015) 145–154152Dibromomaleimide (92 mg, 0.36 mmol) and K2CO3 (5 mg, 0,036 mmol) were added to a solution of
2-bromo-N-(4-chlorophenethyl)acetamide (DIB-5)(50 mg, 0.18 mmol) in acetone (5 mL). The mixture
was stirred at room temperature for three days, then the solvent was distilled and the crude was
puriﬁed on silica gel (cyclohexane/AcOEt 7:3) to afford N-(4-chlorophenethyl)-2-(3,4-dibromo-2,5-
dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetamide (1.06 g, 70% yield) as a yellow solid; 1H NMR (400 MHz,
CDCl3): δ 7.31 (d, J¼8.4 Hz, 2H), 7.14 (d, J¼8.4 Hz, 2H), 5.59 (bs, 1H), 3.86 (s, 2H), 3.53 (app q, J¼7.1 Hz,
2H), 2.83 (t, J¼7.1 Hz, 2H).
2.3. Ligation reactions
See Scheme 2.
2.3.1. Preparation of N-(4-chlorophenethyl)-2-((1-(11-hydroxyundecyl)-4,5,6,7,8,9-hexahydro-1H-
cycloocta[d][1,2,3]triazol-4-yl)oxy)acetamide and N-(4-chlorophenethyl)-2-((1-(11-hydroxyundecyl)-
4,5,6,7,8,9-hexahydro-1H-cycloocta[d][1,2,3]riazol-9-yl)oxy)acetamide (20)
N-(4-chlorophenethyl)-2-(cyclooct-2-yn-1-yloxy)acetamide 16 (10 mg, 0.030 mmol) was added to
a methanol (1 mL) solution of 11-azidoundecan-1-ol (6.7 mg, 0.031 mmol). The solution was stirred at
room temperature (3 h). Then, the volatiles were evaporated and the crude was puriﬁed on silica gel
using cyclohexane/EtOAc (50/50–20/80) to obtain the expected compound as a colorless oil
corresponding to a mixture of regioisomers 20 (11.0 mg, 68%); 1H NMR (400 MHz, CDCl3): δ 7.69–
7.62 (br m, 0.5H, 0.5 NH), 7.30–7.23 (m, 2H, Har), 7.10–7.20 (m, 2H, Har), 6.41–6.76 (br m, 0.5H, 0.5 NH),
4.71–4.65 (m, 1H), 4.12–4.25 (m, 2H), 4.03 (d, 1H, J¼15.7 Hz, CHH0O), 4.03 (d, 1H, J¼15.7 Hz, CHH0O),
3.67–3.51 (m, 4H), 2.92–2.82 (m, 3H), 2.75–2.68 (m, 4H, 2 CH2), 1.87–1.64 (m, 2H, CH2), 1.61–1.56 (m,
6H), 1.33–1.25 (m, 18H); 13C NMR (100 MHz, CDCl3): δ 20.8, 22.0, 22.3, 24.7, 25.7, 26.7, 28.9, 29.0, 29.3,
29.3, 29.4, 29.7, 30.3, 30.4, 32.6, 30.4, 32.6, 32.8, 34.8, 34.9, 39.7, 39.8, 47.8, 63.0, 63.0, 67.5, 68.5, 75.4,
128.6, 128.8, 130.0, 130.2, 137.5, 170.1; MS (ESI) m/z calcd for C29H45ClN4O3Hþ 533.3258 [35Cl],
535.3258 [37Cl]; found 533.3247 [35Cl], 535.3226 [37Cl].
2.3.2. Preparation of N-(4-chlorophenethyl)-4-ﬂuoro-1-(11-hydroxyundecyl)-4,5,6,7,8,9-hexahydro-1H-
cycloocta[d][1,2,3]triazole-4-carboxamide and N-(4-chlorophenethyl)-9-ﬂuoro-1-(11-hydroxyundecyl)-
4,5,6,7,8,9-hexahydro-1H-cycloocta[d][1,2,3]triazole-9-carboxamide (21)
N-(4-chlorophenethyl)-1-ﬂuorocyclooct-2-yne carboxamide 17 (8.6 mg, 0.028 mmol) was
added to a methanol (1 mL) solution of 11-azidoundecan-1-ol (6.0 mg, 0.028 mmol). The
solution was stirred at room temperature (5 h). Then, the volatiles were evaporated and the
crude was puriﬁed on silica gel using cyclohexane/EtOAc (50/50–20/80) to obtain the expected
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NMR (400 MHz, CDCl3): δ 7.36–7.32 (m, 2H, 2 Har), 7.20–7.13 (m, 2H, 2 Har), 6.98–7.00 (br s, 0.5H,
0.5 NH), 6.54 (s, 0.5H, 0.5 NH), 4. 26–4.02 (m, 2H, CH2), 3.66–3.48 (m, 4H, 2 CH2), 2.95–2.82 (m,
4H, 2 CH2), 1.82–1.43 (m, 8H), 1.30–1.26 (m, 18H); 13C NMR (100 MHz, CDCl3) δ (ppm): 21.4, 22.1,
22.1, 22.5, 22.6, 23.3, 24.0, 25.1, 25.7, 26.1, 26.2, 26.5, 26.7, 28.9, 29.0, 29.3, 29.3, 29.3, 29.4, 29.8,
30.4, 32.8, 33.1, 33.4, 34.8, 34.8, 35.0, 40.4, 40.5, 48.0, 49.8, 49.9, 63.0, 128.7, 129.0, 130.0, 130.3,
132.8, 136.4, 137.2, 142.3, 142.5, 145.8, 145.9; MS (ESI) m/z calcd. for C28H42ClFN4O2Hþ 521.30;
found 521.20.
2.3.3. Preparation of N-(4-chlorophenethyl)-2-(diphenylphosphoryl)-N0-(11-hydroxyundecyl)
terephthalamide (22)
1-Azido-11-hydroxyundecane (4.2 mg, 0.02 mmol) was added to a THF/H2O (600 mL/200 mL)
solution of methyl 4-((4-chlorophenethyl)carbamoyl)-2-(diphenylphosphino)benzoate 18 (10 mg,
0.02 mmol). The solution was stirred at room temperature (16 h). The volatiles were evaporated
and the N-(4-chlorophenethyl)-2-(diphenylphosphoryl)-N0-(11-hydroxyundecyl)terephthalamide
(22) was obtained as a colorless oil (13 mg, quant.); 1H NMR (400 MHz, CDCl3): δ 7.80–7.86 (m, 2H,
2 Har), 7.42–7.61 (m, 12H, 12 Har), 7.19 (d, 2H, J¼7.8 Hz, 2 Har), 7.02 (d, 2H, J¼7.8 Hz, 2 Har),
3.50–3.58 (m, 5H), 3.18 (t, J¼7.0 Hz, 1H), 2.76 (t, 4H, J¼7.0 Hz, 2 CH2), 1.46–1.50 (m, 5H), 1.21–1.15
(m, 12H); 13C NMR (100 MHz, CDCl3) δ (ppm): 24.7, 25.7, 25.9, 27.5, 27.8, 28.0, 28.30, 28.32, 28.34,
28.38, 28.4, 28.5, 28.52, 31.8, 33.8, 39.3, 40.1, 62.0, 62.1, 127.7, 127.8, 127.90, 128.94, 129.0,
129.2, 130.0, 130.6, 130.7, 130.74, 130.8, 130.9, 131.2, 131.3, 131.5, 131.6, 161.7, 136.0, 164.6, 165.5; MS
(ESI) m/z calcd for C39H46ClN2O4PHþ 673.2961 [35Cl], 675.2961 [37Cl]; found 673.2976 [35Cl],
675.2963 [37Cl].
2.3.4. Preparation of N-(4-chlorophenethyl)-2-(5,7-dioxotetrahydro-2H-[1,4]dithiino[2,3–c]pyrrol-6(3H)-
yl)acetamide (23)
TCEP (10 mg, 0.04 mmol) and 1,2-ethanedithiol (24 mg, 0.04 mmol) were added to a CH2Cl2 (1 mL)
solution of N-(4-chlorophenethyl)-2-(3,4-dibromo-2,5-dioxo-2,5-dihydro-1 H-pyrrol-1-yl)acetamide
19 (9 mg, 0.02 mmol). The mixture was stirred at room temperature (16 h). H2O (2 mL) was added and
the layers were separated. The organic layer was evaporated to obtained 23 (50% yield after silica gel
M. Vittoria Spanedda et al. / Data in Brief 5 (2015) 145–154154column with cyclohexane/EtOAc 50/50–20/80); MS (ESI) m/z calcd. for C16H15ClN2O3S2Hþ 383.0213
[35Cl]; found 383.0283 [35Cl].Appendix A. Supporting information
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2015.08.014.References
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